|
General Information
|
|
|
Product
|
MYLK3 Antibody
|
|
Description
|
Affinity Purified Myosin light chain kinase 3 Antibody
|
|
Verified Applications
|
ELISA, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 10-60 on human Myosin light chain kinase 3 protein.
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.5-1.5 µg/µl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Form
|
Affinity Purified
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
ELISA
|
1:50,000
|
|
Immunoprecipitation
|
1:200
|
|
Western Blot
|
1:2,500-1:5,000
|
|
Protein
|
|
Uniprot #
|
Q32MK0
|
|
Overview
|
Kinase that phosphorylates MYL2 in vitro. Promotes sarcomere formation in cardiomyocytes and increases cardiomyocyte contractility.
|
|
Molecular Function
|
ATP binding
calmodulin-dependent protein kinase activity
myosin light chain kinase activity
|
|
Subcellular Location
|
Cytoplasm
|
|
Expression
|
Restricted to heart.
|
|
Structure
|
Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family.
|
|
Alternative Nomenclature
|
caMLCK antibody
cardiac MLCK antibody
Cardiac MyBP C associated Ca/CaM kinase antibody
MLC kinase antibody
MLCK antibody
MLCK2 antibody
Mylk3 antibody
Myosin light chain kinase 3 antibody
Putative myosin light chain kinase 3 antibody
|
| |
|
MYLK3 Antibody BIOTIN
MYLK3 Antibody FITC
MYLK3 Blocking Peptide
MYLK3 Positive Control
